This site is intended for healthcare professionals
  • Home
  • /
  • Guidelines
  • /
  • Non-Hodgkin lymphoma
  • /
  • Diffuse large B-cell lymphoma (DLBCL): ESMO Clinic...

Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Read time: 1 mins
Last updated:1st Aug 2015
Diffuse Large B-Cell Lymphoma: ESMO Clinical Practice Guidelines - European Society for Medical Oncology (ESMO)

Diffuse large B-cell lymphoma is relatively common and represents 30%–58% of non-Hodgkin’s lymphomas. The updated ESMO Clinical Practice Guidelines provide information on the current management of diffuse large B-cell lymphoma including recommendations for screening and diagnosis, staging and risk assessment and stage-matched therapeutic strategies including specific recommendations for young and elderly, low-to-high risk subgroups.


Read full guideline